The Pennant Group, Inc. (PNTG)
Nasdaq: PNTG · Services-Health Services · Eagle, ID · filing with the SEC since 2019
Grade6.3
◀ Past 6.9● Present 6.5▶ Future 5.4
Who owns The Pennant Group, Inc.
As filed with the SECHolders of 5% or more
3
Van Berkom & Associates Inc. holds 9% of Common Shares, as its SCHEDULE 13G/A filed Jan 20, 2026 says.
Directors and officers
12
report now, of 17 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Van Berkom & Associates Inc.
SCHEDULE 13G/A · filed Jan 20, 2026 · Common Shares · 0% in Nov 5, 2025
Wasatch Advisors LP
Vanguard Capital Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
Fmr LLC
SCHEDULE 13G/A · filed Sep 8, 2025 · COMMON STOCK · reported falling below 5%
8 Knots Management, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.04% in Nov 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What PNTG reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Acquisition of Certain Signature Group, LLC Operations
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
Acquisition of UnitedHealth Group Incorporated and Amedisys, Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
230 subsidiaries in 1 country, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
9sales
0purchases
7sales on a scheduled plan
3people selling
$700,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 27, 2025 to Oct 27, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 27, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 18 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Guerisoli Brent | Chief Executive Officer | 7 | $600,000 | 6 | 0 | $0 |
| Steik Jason Paul | Chief Clinical Officer | 1 | $100,000 | 1 | 0 | $0 |
| Cheney Kirk Sterling | EVP, GC and Corp Secy | 1 | $100,000 | 0 | 0 | $0 |